Adherence to Acute Migraine Medication: What Does It Mean, Why Does It Matter?

被引:33
作者
Katic, Bozena J. [1 ,2 ]
Krause, Steven J. [3 ]
Tepper, Stewart J. [3 ]
Hu, Henry X. [1 ]
Bigal, Marcelo E. [4 ,5 ]
机构
[1] Merck & Co Inc, Global Outcomes Res, Whitehouse Stn, NJ USA
[2] Temple Univ, Sch Pharm, Ctr Pharmaceut Hlth Serv Res, Philadelphia, PA 19122 USA
[3] Cleveland Clin, Neurol Inst, Ctr Headache & Pain, Cleveland, OH 44106 USA
[4] Merck & Co Inc, Sci Affairs, Whitehouse Stn, NJ USA
[5] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源
HEADACHE | 2010年 / 50卷 / 01期
关键词
medication adherence; triptan; underutilization; medication compliance; acute migraine treatment; migraine treatment decision; BEHAVIORAL FACILITATION; PROPHYLACTIC MEDICATION; CONSULTING BEHAVIOR; PATIENT-ADHERENCE; FUTURE-DIRECTIONS; CLINICAL-PRACTICE; HEADACHE PATIENTS; DECISION-MAKING; ANALGESIC USE; TRIPTANS;
D O I
10.1111/j.1526-4610.2009.01535.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Proper use of medications is an important part of successfully managing migraine headache, yet migraineurs frequently switch, discontinue, or delay taking effective prescription therapies such as triptans. Medication persistence in the treatment of chronic-episodic disorders such as migraine is not well understood. In this article we review this topic, by critically reviewing studies conducted using pharmacy claims, clinical records, survey, and patient-reported data to explore acute medication use for migraine headache. While efficacy, cost, drug tolerability, and side effects impact whether a patient takes migraine medication, low perceived disease importance and factors related to the patient's internal decision-making process play a strong role in the sustained use of acute medication for migraine attack. We propose a model that combines the patient's perceived severity of migraine, their beliefs regarding the safety of acute medications, and factors related to the physician-patient relationship to identify migraineurs at high risk for medication adherence problems.
引用
收藏
页码:117 / 129
页数:13
相关论文
共 66 条
[11]   Determinants of patient satisfaction with migraine therapy [J].
Davies, GM ;
Santanello, N ;
Lipton, R .
CEPHALALGIA, 2000, 20 (06) :554-560
[12]   Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention study [J].
Diamond, Seymour ;
Bigal, Marcelo E. ;
Silberstein, Stephen ;
Loder, Elizabeth ;
Reed, Michael ;
Lipton, Richard B. .
HEADACHE, 2007, 47 (03) :355-363
[13]   Depression is a risk factor for noncompliance with medical treatment -: Meta-analysis of the effects of anxiety and depression on patient adherence [J].
DiMatteo, MR ;
Lepper, HS ;
Croghan, TW .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (14) :2101-2107
[14]   How clinicians can detect, prevent and treat medication overuse headache [J].
Dodick, D. W. ;
Silberstein, S. D. .
CEPHALALGIA, 2008, 28 (11) :1209-1217
[15]   PATIENT NONCOMPLIANCE - DEVIANCE OR REASONED DECISION-MAKING [J].
DONOVAN, JL ;
BLAKE, DR .
SOCIAL SCIENCE & MEDICINE, 1992, 34 (05) :507-513
[16]   Patients' preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine [J].
Dowson A.J. ;
Tepper S.J. ;
Dahlöf C. .
The Journal of Headache and Pain, 2005, 6 (3) :112-120
[17]   Treatment adherence in chronic disease [J].
Dunbar-Jacob, J ;
Mortimer-Stephens, MK .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 :S57-S60
[18]   IMPACT OF MIGRAINE AND TENSION-TYPE HEADACHE ON LIFE-STYLE, CONSULTING BEHAVIOR, AND MEDICATION USE - A CANADIAN POPULATION SURVEY [J].
EDMEADS, J ;
FINDLAY, H ;
TUGWELL, P ;
PRYSEPHILLIPS, W ;
NELSON, RF ;
MURRAY, TJ .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1993, 20 (02) :131-137
[19]  
EISEN S, 1991, DEV MORE CLIN MEANIN, P225
[20]  
Etemad Lida R, 2005, J Manag Care Pharm, V11, P137